V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240001734 | 240009357 | 1.55 | 71.5 | null | 2018-06-05 | 2018-06-27 | Rituximab | null | null | RITUXIMAB | 101577088 |
| 240001736 | 240009358 | null | null | null | 2021-08-25 | 2021-08-26 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100328354 |
| 240001741 | 240009361 | 1.86 | 75.5 | null | 2016-07-05 | 2016-07-05 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 101419440 |
| 240001743 | 240009362 | 0 | 84.8 | null | 2017-04-05 | 2017-04-05 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 101725126 |
| 240001746 | 240009363 | 1.66 | 72.5 | Curative (C) | 2019-03-30 | 2019-03-30 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101363262 |
| 240001749 | 240009364 | 1.72 | 60.7 | 03 | null | 2017-12-12 | null | Y | null | TRIAL UNSPECIFIED | 101345435 |
| 240001752 | 240009367 | 1.65 | 87.4 | null | null | 2016-05-30 | null | null | N | METHOTREXATE | 100234926 |
| 240001762 | 240009369 | null | null | Palliative (P) | 2019-09-18 | 2019-09-18 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101582161 |
| 240001771 | 240009372 | 1.77 | 43.45 | null | null | 2017-09-08 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 101693311 |
| 240001787 | 240009375 | 0 | 70 | null | 2019-12-04 | 2019-12-04 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101533494 |
| 240001797 | 240009379 | 1.59 | 74 | null | null | 2019-04-20 | null | null | null | RITUXIMAB | 100589970 |
| 240001809 | 240009381 | 0 | 87.5 | null | null | 2020-06-02 | null | null | null | HYDROXYCARBAMIDE | 100465468 |
| 240001816 | 240009383 | 1.6 | 54 | Adjuvant (A) | 2019-06-19 | 2019-06-19 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101132644 |
| 240001818 | 240009384 | 1.69 | 62.8 | null | 2021-09-09 | 2021-09-09 | AML 18 TRIAL | null | null | CYTARABINE | 101189206 |
| 240001823 | 240009385 | 1.66 | 62.3 | null | 2018-08-24 | 2018-08-24 | AML 18 TRIAL | null | N | AML18 TRIAL | 100380250 |
| 240001828 | 240009386 | 1.8 | 62.8 | Palliative (P) | 2020-01-25 | 2020-02-10 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100548346 |
| 240001853 | 240009390 | 1.74 | 47.8 | null | 2021-09-08 | 2021-09-09 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 101263532 |
| 240001854 | 240009391 | null | null | Curative (C) | 2017-05-26 | 2017-05-27 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101246132 |
| 240001858 | 240009392 | 1.59 | 96.65 | Palliative (P) | null | 2019-02-20 | null | 02 | null | RITUXIMAB | 100599723 |
| 240001863 | 240009394 | 1.67 | 82.8 | null | 2020-04-14 | 2020-04-26 | AML 18 TRIAL | null | null | HYDROXYCARBAMIDE | 101200067 |
| 240001881 | 240009398 | 1.64 | 68.4 | null | null | 2020-08-03 | null | 02 | null | CHOP R | 100980786 |
| 240001882 | 240009399 | 1.8 | 0 | Adjuvant (A) | 2019-02-07 | 2019-02-09 | Hydroxycarbamide | null | null | HYDROXYCARBAMIDE | 100051396 |
| 240001888 | 240009400 | 1.72 | 86 | Palliative (P) | null | 2021-05-09 | null | null | N | AZACITIDINE | 100524121 |
| 240001892 | 240009402 | 1.82 | 69.3 | Curative (C) | null | 2019-10-10 | null | 02 | N | RITUXIMAB | 100899672 |
| 240001899 | 240009405 | 1.54 | 64.25 | Adjuvant (A) | 2018-04-26 | 2018-05-06 | Hydroxycarbamide | 02 | null | HYDROXYCARBAMIDE | 100190848 |
| 240001903 | 240009406 | 1.65 | 45.7 | null | 2016-08-21 | 2016-08-22 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 100923586 |
| 240001905 | 240009407 | null | null | null | 2022-05-02 | 2022-05-06 | Hydroxycarbamide | N | N | HYDROXYCARBAMIDE | 100784879 |
| 240001909 | 240009408 | 1.75 | 112 | null | 2020-01-04 | 2020-01-05 | Hydroxycarbamide | 02 | N | HYDROXYCARBAMIDE | 101780842 |
| 240001912 | 240009409 | 1.65 | 88 | Palliative (P) | null | 2021-12-04 | Venetoclax | null | N | ALL INT GDE 2019 MAINTENANCE | 100060591 |
| 240001922 | 240009410 | 1.69 | 80.2 | 03 | null | 2019-12-30 | Ibrutinib + Rituximab | null | N | CVP R | 101630483 |
| 240001929 | 240009412 | 1.63 | 76.4 | null | null | 2022-05-20 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | RUXOLITINIB | 100551932 |
| 240001939 | 240009413 | 1.7 | 28 | null | null | 2020-12-25 | null | null | null | ALL UKALL2011 IND B | 100741940 |
| 240001943 | 240009414 | null | 117 | 03 | null | 2021-05-24 | null | null | Y | CNS LGG2004 03 VINC + CARBO | 100562552 |
| 240001951 | 240009415 | 1.63 | 59.6 | Adjuvant (A) | null | 2021-09-18 | GEMTUZUMAB OZOGAMICIN | null | N | TRIPLE INTRATHECAL | 100267105 |
| 240001962 | 240009416 | 1.67 | 66.8 | null | null | 2016-09-21 | DHAP - R | null | null | ARSENIC TRIOXIDE + TRETINOIN | 100563728 |
| 240001964 | 240009417 | 1.7 | 81 | Curative (C) | null | 2017-08-12 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | TRIPLE INTRATHECAL | 101222255 |
| 240001972 | 240009418 | 1.58 | 87.4 | Curative (C) | 2018-06-11 | 2018-06-11 | PEG INTERFERON | 02 | N | AML MYECHILD 01 TRIPLE IT | 100926859 |
| 240001977 | 240009419 | 1.56 | 69 | Curative (C) | 2022-03-16 | 2022-03-20 | Bortezomib +/- Dexamethasone | 02 | N | AML INTERIM GUIDELINES FLAG-IDA | 100102552 |
| 240001979 | 240009420 | 1.73 | 65 | null | null | 2020-06-09 | null | null | null | IMATINIB | 100817622 |
| 240001980 | 240009421 | 1.77 | 72 | null | null | 2018-12-13 | DA | null | null | CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100601255 |
| 240001984 | 240009422 | 1.72 | 84.1 | Palliative (P) | 2020-08-18 | 2020-08-24 | Trial Unspecified | 02 | N | CYTARABINE + DAUNORUBICIN + GEMTUZUMAB OZOGAMICIN | 101821522 |
| 240002001 | 240009425 | 1.76 | 66.7 | null | null | 2017-02-07 | null | null | null | CYTARABINE HIGH DOSE | 101671093 |
| 240002008 | 240009427 | 0 | 42.1 | Palliative (P) | 2019-04-07 | 2019-04-13 | AML MyeChild | 02 | N | CNS LOW GRADE GLIOMA VINBLASTINE | 100372179 |
| 240002011 | 240009429 | 1.71 | 82.7 | Curative (C) | 2021-09-29 | 2021-10-04 | null | 02 | N | AML MYECHILD 01 A MITOZANTRONE/CYTARABINE | 100881926 |
| 240002012 | 240009430 | 1.82 | 88.5 | Curative (C) | 2018-09-29 | 2018-10-06 | ALL UKALL2011 Maintenance A1 | 02 | null | VENETOCLAX | 100583867 |
| 240002013 | 240009431 | 1.73 | 52.1 | null | null | 2019-04-11 | null | null | null | CYCLOPHOSPHAMIDE | 101003263 |
| 240002018 | 240009432 | 1.62 | 29.8 | null | null | 2016-09-24 | null | N | null | METHOTREXATE + RITUXIMAB | 100621522 |
| 240002021 | 240009433 | 1.82 | 73.9 | Disease modification (D) | 2019-05-10 | 2019-05-24 | Brentuximab | 02 | N | IBRUTINIB | 100662522 |
| 240002028 | 240009434 | 1.54 | 98.75 | null | 2017-12-21 | 2017-12-27 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | null | BEACOPP | 100853005 |
| 240002033 | 240009435 | 1.43 | 34.8 | null | 2022-02-15 | 2022-02-15 | null | 02 | null | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 101812728 |